Cargando…
Safety and Effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial
BACKGROUND: In cardiopulmonary bypass (CPB) patients, fibrinolysis may enhance postoperative inflammatory response. We aimed to determine whether an additional postoperative dose of antifibrinolytic tranexamic acid (TA) reduced CPB-mediated inflammatory response (IR). METHODS: We performed a randomi...
Autores principales: | Jiménez, Juan J, Iribarren, José L, Brouard, Maitane, Hernández, Domingo, Palmero, Salomé, Jiménez, Alejandro, Lorente, Leonardo, Machado, Patricia, Borreguero, Juan M, Raya, José M, Martín, Beatriz, Pérez, Rosalía, Martínez, Rafael, Mora, María L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206427/ https://www.ncbi.nlm.nih.gov/pubmed/21999189 http://dx.doi.org/10.1186/1749-8090-6-138 |
Ejemplares similares
-
Safety and effectiveness of different treatment regimes with tranexamic acid in elective cardiopulmonary bypass patients
por: Iribarren, JL, et al.
Publicado: (2011) -
Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial
por: Jimenez, Juan J, et al.
Publicado: (2007) -
Factors associated with excessive bleeding in cardiopulmonary bypass patients: a nested case-control study
por: Jimenez Rivera, Juan J, et al.
Publicado: (2007) -
Relative adrenal insufficiency and hemodynamic status in cardiopulmonary bypass surgery patients. A prospective cohort study
por: Iribarren, José L, et al.
Publicado: (2010) -
Tranexamic acid effects on postoperative bleeding in cardiopulmonary bypass surgery according to the plasminogen activator inhibitor-1 polymorphism
por: Brouard, M, et al.
Publicado: (2008)